Search research articles
Contact Us
Filters
Showing results (61-70 of 65) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 65 results.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
July 5, 2016
Do refined consensus guidelines improve the uniformity of clinical target volume delineation for rectal cancer? Results of a national review project
Ines Joye, Gilles Macq, Evelien Vaes, et al.
British Journal of Cancer
|
January 6, 2026
Favorable histo-molecular remodeling of pancreatic ductal adenocarcinoma after neoadjuvant FOLFIRINOX followed by high-dose stereotactic body radiotherapy
Christelle Bouchart, Oier Azurmendi Senar, Julie Navez, et al.
Acta Oncologica (Stockholm, Sweden)
|
January 13, 2021
Rationale and design of REGINA, a phase II trial of neoadjuvant regorafenib, nivolumab, and short-course radiotherapy in stage II and III rectal cancer
Giacomo Bregni, Caroline Vandeputte, Andrea Pretta, et al.
JAMA Oncology
|
July 10, 2025
Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer
Alessandro Audisio, Chiara Gallio, Vaneja Velenik, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 6, 2026
Mismatch repair deficiency or microsatellite instability in locally advanced rectal cancer patients treated with total neoadjuvant therapy
Nada Benhima, Alessandro Audisio, Chiara Gallio, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 65) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 65 results.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
July 5, 2016
Do refined consensus guidelines improve the uniformity of clinical target volume delineation for rectal cancer? Results of a national review project
Ines Joye, Gilles Macq, Evelien Vaes, et al.
British Journal of Cancer
|
January 6, 2026
Favorable histo-molecular remodeling of pancreatic ductal adenocarcinoma after neoadjuvant FOLFIRINOX followed by high-dose stereotactic body radiotherapy
Christelle Bouchart, Oier Azurmendi Senar, Julie Navez, et al.
Acta Oncologica (Stockholm, Sweden)
|
January 13, 2021
Rationale and design of REGINA, a phase II trial of neoadjuvant regorafenib, nivolumab, and short-course radiotherapy in stage II and III rectal cancer
Giacomo Bregni, Caroline Vandeputte, Andrea Pretta, et al.
JAMA Oncology
|
July 10, 2025
Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer
Alessandro Audisio, Chiara Gallio, Vaneja Velenik, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 6, 2026
Mismatch repair deficiency or microsatellite instability in locally advanced rectal cancer patients treated with total neoadjuvant therapy
Nada Benhima, Alessandro Audisio, Chiara Gallio, et al.
Page
of 7